Position in EOLS
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$141,909
-$75,306 QoQ
Shares Held
20,448
-37.4% QoQ
Ownership
0.031%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#85
of 158 holders
Holding Since
Sep 2021
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EOLS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026FOX RUN MANAGEMENT, L.L.C. holds $6,581,949 across 12 Drug Manufacturers - Specialty & Generic names. EOLS ranks #10 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
29,511 | $2,120,660 | |
| 2 | INDV |
Indivior Pharmaceuticals, Inc.
|
24,876 | $1,020,662 | |
| 3 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
44,817 | $804,913 | |
| 4 | BHC |
Bausch Health Companies Inc.
|
139,728 | $688,859 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
18,952 | $466,408 | |
| 6 | AMPH |
Amphastar Pharmaceuticals, Inc.
|
14,556 | $293,740 | |
| 7 | TLRY |
Tilray Brands, Inc.
|
63,112 | $283,372 | |
| 8 | AMRX |
Amneal Pharmaceuticals, Inc.
|
16,028 | $277,444 |
All Filings in EOLS
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $141,909 | 20,448 | Shares | Sole | 2026-08-04 | |
| 2025-12-31 | $217,215 | 32,664 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $167,038 | 27,205 | Shares | Sole | 2025-11-12 | |
| 2023-12-31 | $200,027 | 18,996 | Shares | Sole | 2024-02-13 | |
| 2022-12-31 | $81,588 | 10,864 | Shares | Sole | 2023-02-07 | |
| 2021-09-30 | $78,790 | 10,340 | Shares | Sole | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||